Result of GM and Move to Premium Listing

RNS Number : 1556D
Axiom European Financial Debt Fd Ld
05 October 2018
 

5 October 2018

Axiom European Financial Debt Fund Limited

Result of General Meeting and Intention to Proceed with Premium Listing

Axiom European Financial Debt Fund Limited (the "Company") is pleased to announce that, at the general meeting held earlier today (the "General Meeting"), all resolutions (the "Resolutions") put forward were passed.  The resolutions put forward at the General Meeting and the votes cast are detailed at the end of this announcement.

Following the passing of the Resolutions, the Company's shares are expected to be eligible for admission to the premium listing segment of the UKLA's Official List and to trading on the premium segment of the main market of the London Stock Exchange (together, a "Premium Listing").  Accordingly, the Company intends to apply for all of its issued shares, being 85,452,024 ordinary shares, to be admitted to a Premium Listing ("Admission") and Admission is expected to occur with effect from 8:00am on 15 October 2018.  The Company's ticker, ISIN, LEI and SEDOL will remain unchanged.

 

In conjunction with the application for admission to a Premium Listing, the Company is required to make a statement as to the sufficiency of its working capital.  Accordingly, the Company is of the opinion that the working capital available to it is sufficient for its present requirements, that is for at least 12 months from the date of this announcement.

 

For further information please contact:

 

Axiom Alternative Investments SARL

David Benamou, Managing Partner

Jerome Legras, Managing Partner

 

+44(0)20 3807 0670

 

Winterflood Securities Limited

Joe Winkley

Neil Morgan

 

+44(0)20 3100 0000

 

 

 

Resolution

For

Against

Abstain

Result

Special Resolution

 




1.

Conditional on the Company's ordinary shares of no par value ("Shares") being admitted to listing on the premium segment of the main market of the London Stock Exchange and the premium listing segment of the official list of the UK Listing Authority ("Premium Listing"), to amend the articles of incorporation of the Company (the "Articles"), as detailed in the notice of General Meeting.

23,319,355

0

0

Resolution

carried

Extraordinary Resolution

 




2.

Conditional on (i) the Shares being admitted to Premium Listing, and (ii) the passing of special resolution 1 above, to dis-apply pre-emption rights set out in Article 2.6 of the Articles (as amended pursuant to resolution 1 above) in relation to the issue of up to:

i. an aggregate number of 500 million Shares pursuant to the placing programme proposed to be put in place by the Company and described in the circular dated 14 September 2018 (the "Circular") (the "Placing Programme"); and

ii.        such number of Shares as is equal to 10 per cent of the number of Shares in issue immediately following the passing of this resolution,

provided that such disapplication and exclusion shall expire on the date which is 18 months from the date of this resolution becoming unconditional or, if earlier (in the case of (i) only), at the termination of the Placing Programme, save that the Company may before such expiry make an offer or agreement which would or might require Shares to be allotted after such expiry and the directors of the Company may allot Shares in pursuance of such an offer or agreement as if the disapplication and exclusion conferred hereby had not expired.

23,319,355

0

0

Resolution

carried

Ordinary Resolution

 




3.

Conditional on the Shares being admitted to Premium Listing, the Company shall adopt the text set out in Appendix 1 to the Circular as its investment policy, in substitution for its current published investment policy.

23,319,355

0

0

Resolution

carried

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEAFESEEAPFFF
UK 100